CartiHeal Enrolls First Agili-C Patient on East Coast

CartiHeal enrolled the first patient in the Investigational Device Exemption (IDE) pivotal study of Agili-C™ on the East Coast. NYU Langone Health's Sports Medicine Center, one of 15 U.S. sites in the trial, will enroll 20 patients with major knee cartilage injuries.

To date, over 100 of the minimum 250 patients are enrolled in the trial,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us